Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
RecBio
company
About
Focusing on major innovative vaccines with independent intellectual property rights.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥1.50B
- Industries
- Health Care,Life Science
- Founded date
- Jan 1, 2012
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥1.50B
RecBio has raised a total of
¥1.50B
in funding over 2 rounds. Their latest funding was raised on
Nov 11, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 11, 2020 | Series B | ¥1.50B | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
RecBio is funded by 2 investors.
HT Capital
and China Everbright Investment Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
HT Capital
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
